TIGeR-PaC Candidate Criteria

To Participate in the TIGeR-PaC study, Candidate Patients Must Meet the Following Minimum Criteria:

  • Diagnosis of locally advanced pancreatic cancer
  • Not a candidate for surgery
  • No prior therapy for pancreatic cancer or no more than 3 treatments with gemcitabine-Abraxane

Note: Before a patient is enrolled in the study, the patient must be evaluated by one of the physicians in the TIGeR-PaC study.  The physician will review the study in detail with the patient to ensure that the study is well-suited for the patient.

If you or your patient meet the minimum criteria or have questions about the TIGeR-PaC trial, contact RenovoRx. For more information visit bit.ly/TIGeR-PaC.